Case

Severe AR, Preserved EF, but LVESD Is Above Threshold: How the Evaluation Frame Changes

An asymptomatic patient with confirmed severe AR. LVEF is 58% — above the 55% threshold. But LVESD is 53 mm, above the 50 mm threshold. The Severity Tool shows Stage C1. The Intervention Navigator shows a different path.

Clinical scenario

LVEF 58% — above 55%. Does the LVESD threshold still matter?

57-year-old male. Routine follow-up echo in known chronic AR. No exertional symptoms, no reduced exercise tolerance. BP 148/54 mmHg. Wide pulse pressure on exam.

Echo findings

Parameter	Value	Threshold / Interpretation
VC width	0.66 cm	≥ 0.60 cm = severe echo sign
PISA EROA	0.33 cm²	≥ 0.30 cm² = severe echo sign
Regurgitant fraction	53%	≥ 50% = severe echo sign
Holodiastolic reversal	Descending aorta	Counted severe echo sign
LVEF	58%	> 55% — LVEF threshold does NOT fire
LVESD	53 mm	> 50 mm — LVESD threshold fires (strict >50)
LVEDD	62 mm	≤ 65 mm — LVEDD threshold does not fire
Symptoms	Asymptomatic	Symptomatic threshold does not fire

AR Severity Tool interpretation

Four severe echo signs are present: VC, EROA, RegFrac, and descending holodiastolic reversal. Four severe signals → severe_ar_pattern (Red). With asymptomatic status, LVEF 58%, and LVEDD 62 mm entered, the LV staging panel shows Stage C1 — asymptomatic, LVEF ≥ 55%, LVEdd ≤ 65 mm. The LV staging in the Severity Tool is based on LVEF and LVEdd only; LVESD is not part of its staging logic.

AR Intervention Navigator interpretation

Severity context is set to confirmed_severe. Symptoms are asymptomatic. Step 6 (LVEF ≤ 55%): LVEF 58% is above 55% — this step does NOT fire. Step 7 (LVESD > 50 mm): LVESD 53 mm is strictly above 50 mm — this step fires. Evaluation class = asymptomatic_severe_lv_dilation. Key = lvesd_above_50. Next step = serial_lv_imaging_dilation. The caution displayed confirms that the LVESD threshold is strictly above 50 mm, and that LVESD 50 mm exactly would not have triggered this path.

Stage C1 in the Severity Tool, Step 7 in the Navigator

The Severity Tool shows Stage C1 because it uses LVEF and LVEdd — both within C1 range. The Navigator shows asymptomatic_severe_lv_dilation because it evaluates LVESD separately. These are not contradictory: the two tools use different LV input fields.

LVEF 58% — above the 55% threshold. Does LVESD 53 mm change the evaluation frame?

1.
No — LVEF is above 55%, so the LVEF pathway does not apply; surveillance is appropriate△ Consider
Correct that LVEF is above the Step 6 threshold. But LVESD >50 mm triggers Step 7 independently — a separate evaluation path.
2.
Yes — LVESD >50 mm triggers a separate evaluation path even with preserved LVEF✓ Recommended
The LVESD threshold (strictly >50 mm) and the LVEF threshold (≤55%) are independent. LVESD 53 mm fires Step 7 regardless of LVEF.
3.
LVEDD 62 mm is borderline — use the borderline path instead⚠ Not recommended
LVEDD 62 mm is below the 65 mm threshold — Step 8 does not fire. LVESD 53 mm is the relevant threshold here.

Teaching points

The LVEF ≤55% threshold (Step 6) and the LVESD >50 mm threshold (Step 7) are independent evaluation paths. A patient can have LVEF above 55% and still trigger Step 7 if LVESD exceeds 50 mm.
The AR Severity Tool uses LVEF and LVEdd for its staging context. LVESD is only evaluated in the Intervention Navigator. Stage C1 in the Severity Tool and asymptomatic_severe_lv_dilation in the Navigator are not contradictory.
The LVESD threshold is strictly greater-than: LVESD 53 mm fires Step 7; LVESD 50 mm exactly does not.
LVEDD 62 mm is below the 65 mm threshold — Step 8 does not trigger. LVEDD and LVESD thresholds are separate steps with distinct clinical significance.
The asymptomatic_severe_lv_dilation path reflects a different evaluation discussion than the pure surveillance path — the distinction is in the LV dimensional change, even with preserved ejection fraction.

Apply this in practice

Enter severity context, LVEF, and LVESD to see how the Navigator separates the LV pathways.

Open AR Intervention Navigator